{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T02:30:36Z","timestamp":1775183436492,"version":"3.50.1"},"reference-count":71,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T00:00:00Z","timestamp":1575244800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017255","name":"Allergy Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017255","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology and Allergy Clinics of North America"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.iac.2019.09.013","type":"journal-article","created":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T17:07:37Z","timestamp":1573060057000},"page":"111-133","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Safety of Food Oral Immunotherapy"],"prefix":"10.1016","volume":"40","author":[{"given":"Sonia","family":"V\u00e1zquez-Cort\u00e9s","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paloma","family":"Jaqueti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Arasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrianna","family":"Machinena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Montserrat","family":"Alvaro-Lozano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Montserrat","family":"Fern\u00e1ndez-Rivas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.iac.2019.09.013_bib1","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1111\/all.12429","article-title":"EAACI food allergy and anaphylaxis guidelines: diagnosis and management of food allergy","volume":"69","author":"Muraro","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.iac.2019.09.013_bib2","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1111\/all.13124","article-title":"Allergen immunotherapy for IgE-mediated food allergy: a systematic review and meta-analysis","volume":"72","author":"Nurmatov","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.iac.2019.09.013_bib3","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/S0140-6736(19)30420-9","article-title":"Oral immunotherapy for peanut allergy (PACE): a systematic review and meta-analysis of efficacy and safety","volume":"393","author":"Chu","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.iac.2019.09.013_bib4","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/all.13319","article-title":"EAACI guidelines on allergen immunotherapy: IgE-mediated food allergy","volume":"73","author":"Pajno","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.iac.2019.09.013_bib5","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1111\/j.1398-9995.2010.02348.x","article-title":"Life-threatening asthma reaction caused by desensitization to milk","volume":"65","author":"Nieto","year":"2010","journal-title":"Allergy"},{"key":"10.1016\/j.iac.2019.09.013_bib6","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.anai.2014.07.010","article-title":"Life-threatening anaphylaxis to egg and milk oral immunotherapy in asthmatic teenagers","volume":"113","author":"Vazquez-Ortiz","year":"2014","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.iac.2019.09.013_bib7","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/apa.13668","article-title":"Double-blind placebo-controlled challenge showed that peanut oral immunotherapy was effective for severe allergy without negative effects on airway inflammation","volume":"106","author":"Kukkonen","year":"2017","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.iac.2019.09.013_bib8","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/pai.13025","article-title":"Outcome of oral immunotherapy for persistent cow\u2019s milk allergy from 11 years of experience in Finland","volume":"30","author":"Kauppila","year":"2019","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.iac.2019.09.013_bib9","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.jaip.2018.12.006","article-title":"Comparison of international systemic adverse reactions due to allergen immunotherapy","volume":"7","author":"Vidal","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.iac.2019.09.013_bib10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13601-018-0215-x","article-title":"Assessing severity of anaphylaxis: a data-driven comparison of 23 instruments","volume":"8","author":"Eller","year":"2018","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.iac.2019.09.013_bib11","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jaip.2016.11.009","article-title":"World Allergy Organization systemic allergic reaction grading system: is a modification needed?","volume":"5","author":"Cox","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.iac.2019.09.013_bib12","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1111\/all.13408","article-title":"The urgent need for a harmonized severity scoring system for acute allergic reactions","volume":"73","author":"Muraro","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.iac.2019.09.013_bib13","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1056\/NEJMoa1812856","article-title":"AR101 oral immunotherapy for peanut allergy","volume":"379","author":"Vickery","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.iac.2019.09.013_bib14","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jaci.2010.12.1111","article-title":"A\u00a0randomized controlled study of peanut oral immunotherapy (OIT): clinical desensitization and modulation of the allergic response","volume":"127","author":"Varshney","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.013_bib15","first-page":"737","article-title":"Assessing the efficacy of oral immunotherapy for the desensitisation of peanut allergy in children (STOP II): a phase 2 randomised controlled trial","volume":"135","author":"Anagnostou","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.013_bib16","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jaci.2014.11.034","article-title":"Administration of a probiotic with peanut oral immunotherapy: a randomized trial","volume":"135","author":"Tang","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.013_bib17","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.jaci.2014.11.005","article-title":"A\u00a0randomized, double-blind, placebo-controlled pilot study of sublingual versus oral immunotherapy for the treatment of peanut allergy","volume":"135","author":"Narisety","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.013_bib18","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jaci.2016.05.027","article-title":"Early oral immunotherapy in peanut-allergic preschool children is safe and highly effective","volume":"139","author":"Vickery","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.013_bib19","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.jaip.2017.09.016","article-title":"Efficacy and safety of AR101 in oral immunotherapy for peanut allergy: results of ARC001, a randomized, double-blind, placebo-controlled phase 2 clinical trial","volume":"6","author":"Bird","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.iac.2019.09.013_bib20","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/cea.13148","article-title":"Peanut gastrointestinal delivery oral immunotherapy in adolescents: results of the build-up phase of a randomized, double-blind, placebo-controlled trial (PITA study)","volume":"48","author":"Fauquert","year":"2018","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.iac.2019.09.013_bib21","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/pai.12898","article-title":"Low-dose oral immunotherapy for children with anaphylactic peanut allergy in Japan","volume":"29","author":"Nagakura","year":"2018","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.iac.2019.09.013_bib22","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/pai.12914","article-title":"Long-term outcome of peanut oral immunotherapy\u2013real-life experience","volume":"29","author":"Nachshon","year":"2018","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.iac.2019.09.013_bib23","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jaip.2018.10.048","article-title":"Efficacy, safety, and quality of life in a multicenter, randomized, placebo-controlled trial of low-dose peanut oral immunotherapy in children with peanut allergy","volume":"7","author":"Blumchen","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.iac.2019.09.013_bib24","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/all.13604","article-title":"Feasibility of desensitizing children highly allergic to peanut by high-dose oral immunotherapy","volume":"74","author":"Reier-Nilsen","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.iac.2019.09.013_bib25","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jaip.2018.05.023","article-title":"Real-world experience with peanut oral immunotherapy: lessons learned from 270 patients","volume":"7","author":"Wasserman","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.iac.2019.09.013_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaip.2019.04.010","article-title":"First real-world safety analysis of preschool peanut oral immunotherapy","author":"Soller","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.iac.2019.09.013_bib27","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.jaci.2016.08.010","article-title":"Omalizumab facilitates rapid oral desensitization for peanut allergy","volume":"139","author":"MacGinnitie","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.013_bib28","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S2352-4642(19)30029-X","article-title":"Walnut oral immunotherapy for desensitisation of walnut and additional tree nut allergies (Nut CRACKER): a single-centre, prospective cohort study","volume":"3","author":"Elizur","year":"2019","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.iac.2019.09.013_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaip.2019.05.031","article-title":"Efficacy and safety of sesame oral immunotherapy\u2013a real-world, single-center study","author":"Nachshon","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.iac.2019.09.013_bib30","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.jaci.2018.08.041","article-title":"Multicenter, randomized, double-blind, placebo-controlled clinical trial of vital wheat gluten oral immunotherapy","volume":"143","author":"Nowak-W\u0119grzyn","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.013_bib31","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJMoa1200435","article-title":"Oral immunotherapy for treatment of egg allergy in children","volume":"367","author":"Burks","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.iac.2019.09.013_bib32","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1399-3038.2012.01349.x","article-title":"Specific oral tolerance induction with raw hen's egg in children with very severe egg allergy: a randomized controlled trial","volume":"24","author":"Dello Iacono","year":"2013","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.iac.2019.09.013_bib33","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.aller.2012.02.007","article-title":"Specific oral tolerance induction in paediatric patients with persistent egg allergy","volume":"41","author":"Fuentes-Aparicio","year":"2013","journal-title":"Allergol Immunopathol (Madr)"},{"key":"10.1016\/j.iac.2019.09.013_bib34","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1399-3038.2012.01341.x","article-title":"Oral food desensitization in children with IgE-mediated hen\u2019s egg allergy: a new protocol with raw hen\u2019s egg","volume":"24","author":"Meglio","year":"2013","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.iac.2019.09.013_bib35","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/cea.12233","article-title":"Baseline specific IgE levels are useful to predict safety of oral immunotherapy in egg-allergic children","volume":"44","author":"Vazquez-Ortiz","year":"2014","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.iac.2019.09.013_bib36","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.jaip.2015.01.017","article-title":"Oral immunotherapy for egg allergy: a double-blind placebo-controlled study, with post-desensitization follow-up","volume":"3","author":"Caminiti","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.iac.2019.09.013_bib37","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1111\/cea.12604","article-title":"Early sustained unresponsiveness after short-course egg oral immunotherapy: a randomized controlled study in egg-allergic children","volume":"45","author":"Escudero","year":"2015","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.iac.2019.09.013_bib38","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.anai.2016.11.023","article-title":"Efficacy and safety of high-dose rush oral immunotherapy in persistent egg allergic children: a randomized clinical trial","volume":"118","author":"P\u00e9rez-Rangel","year":"2017","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.iac.2019.09.013_bib39","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1111\/all.12905","article-title":"Oral immunotherapy with low allergenic hydrolysed egg in egg allergic children","volume":"71","author":"Giavi","year":"2016","journal-title":"Allergy"},{"key":"10.1016\/j.iac.2019.09.013_bib40","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.alit.2017.07.007","article-title":"Desensitization to a whole egg by rush oral immunotherapy improves the quality of life of guardians: a multicenter, randomized, parallel-group, delayed-start design study","volume":"67","author":"Itoh-Nagato","year":"2018","journal-title":"Allergol Int"},{"key":"10.1016\/j.iac.2019.09.013_bib41","doi-asserted-by":"crossref","DOI":"10.1111\/pai.13087","article-title":"Oral immunotherapy protocol for hen's egg allergic children: improving safety","author":"Machinena","year":"2019","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.iac.2019.09.013_bib42","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.jaci.2008.09.030","article-title":"A\u00a0randomized, double-blind, placebo-controlled study of milk oral immunotherapy for cow's milk allergy","volume":"122","author":"Skripak","year":"2008","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.013_bib43","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jaci.2007.10.029","article-title":"Specific oral tolerance induction in children with very severe cow's milk-induced reactions","volume":"121","author":"Longo","year":"2008","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.013_bib44","doi-asserted-by":"crossref","first-page":"443","DOI":"10.2500\/aap.2009.30.3221","article-title":"A\u00a0new protocol for specific oral tolerance induction in children with IgE-mediated cow's milk allergy","volume":"30","author":"Caminiti","year":"2009","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.iac.2019.09.013_bib45","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.anai.2010.03.015","article-title":"Oral immunotherapy for cow's milk allergy with a weekly up-dosing regimen: a randomized single-blind controlled study","volume":"105","author":"Pajno","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.iac.2019.09.013_bib46","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1111\/j.1365-2222.2011.03749.x","article-title":"Oral desensitization as a useful treatment in 2-year-old children cow\u2019s milk allergy","volume":"41","author":"Martorell","year":"2011","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.iac.2019.09.013_bib47","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1651-2227.2012.02815.x","article-title":"Milk oral immunotherapy is effective in school-aged children","volume":"102","author":"Salmivesi","year":"2013","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.iac.2019.09.013_bib48","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/cea.12012","article-title":"Safety and predictors of adverse events during oral immunotherapy for milk allergy: severity of reaction at oral challenge, specific IgE and prick test","volume":"43","author":"V\u00e1zquez-Ortiz","year":"2013","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.iac.2019.09.013_bib49","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.anai.2013.09.001","article-title":"Increased cow's milk protein-specific IgG4 levels after oral desensitization in 7- to 12-month-old infants","volume":"111","author":"Lee","year":"2013","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.iac.2019.09.013_bib50","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.anai.2013.01.013","article-title":"Efficacy and safety of oral desensitization in children with cow's milk allergy according to their serum specific IgE level","volume":"110","author":"Garc\u00eda-Ara","year":"2013","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.iac.2019.09.013_bib51","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/cea.12528","article-title":"Identification of novel peptide biomarkers to predict safety and efficacy of cow\u2019s milk oral immunotherapy by peptide microarray","volume":"45","author":"Mart\u00ednez-Botas","year":"2015","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.iac.2019.09.013_bib52","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000442157","article-title":"A\u00a0single-center, case-control study of low-dose-induction oral immunotherapy with cow\u2019s milk","volume":"168","author":"Yanagida","year":"2015","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.iac.2019.09.013_bib53","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.jaci.2015.10.005","article-title":"A\u00a0randomized double-blind placebo-controlled study of omalizumab combined with oral immunotherapy for the treatment of cow\u2019s milk allergy","volume":"137","author":"Wood","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.013_bib54","doi-asserted-by":"crossref","first-page":"17453","DOI":"10.1038\/s41598-017-16730-6","article-title":"Oral immunotherapy combined with omalizumab for high-risk cow\u2019s milk allergy: a randomized controlled trial","volume":"7","author":"Takahashi","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.iac.2019.09.013_bib55","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.5415\/apallergy.2018.8.e28","article-title":"Cow's milk oral immunotherapy in real life: 8-year long-term follow-up study","volume":"8","author":"Mota","year":"2018","journal-title":"Asia Pac Allergy"},{"key":"10.1016\/j.iac.2019.09.013_bib56","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1016\/j.jaip.2019.02.007","article-title":"Adverse events in oral immunotherapy for the desensitization of cow\u2019s milk allergy in children: a randomized controlled trial","volume":"7","author":"De Schryver","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.iac.2019.09.013_bib57","first-page":"52","article-title":"Food allergy in children: results of a standardized protocol for oral desensitization","volume":"45","author":"Patriarca","year":"1998","journal-title":"Hepatogastroenterology"},{"issue":"3","key":"10.1016\/j.iac.2019.09.013_bib58","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1046\/j.1365-2036.2003.01468.x","article-title":"Oral desensitizing treatment in food allergy: clinical and immunological results","volume":"17","author":"Patriarca","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.iac.2019.09.013_bib59","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1007\/s10620-006-9245-7","article-title":"Oral specific desensitization in food-allergic children","volume":"52","author":"Patriarca","year":"2007","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.iac.2019.09.013_bib60","first-page":"12","article-title":"Oral desensitization in children with milk and egg allergies obtains recovery in a significant proportion of cases. A randomized study in 60 children with cow's milk allergy and 90 children with egg allergy","volume":"39","author":"Morisset","year":"2007","journal-title":"Eur Ann Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.013_bib61","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1111\/j.1398-9995.2007.01501.x","article-title":"Specific oral tolerance induction in food allergy in children: efficacy and clinical patterns of reaction","volume":"62","author":"Staden","year":"2007","journal-title":"Allergy"},{"key":"10.1016\/j.iac.2019.09.013_bib62","doi-asserted-by":"crossref","first-page":"100010","DOI":"10.1016\/j.waojou.2018.11.008","article-title":"The safety of oral immunotherapy for food allergy during maintenance phase: effect of counselling on adverse reactions","volume":"12","author":"Arasi","year":"2019","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.iac.2019.09.013_bib63","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jaip.2013.10.001","article-title":"Oral immunotherapy for peanut allergy: multipractice experience with epinephrine-treated reactions","volume":"2","author":"Wasserman","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.iac.2019.09.013_bib64","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jaci.2005.12.1303","article-title":"Second symposium on the definition and management of anaphylaxis: summary report","volume":"117","author":"Sampson","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.013_bib65","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s40521-019-00205-2","article-title":"Risk factors for adverse reactions during OIT","volume":"6","author":"Patel","year":"2019","journal-title":"Curr Treat Options Allergy"},{"key":"10.1016\/j.iac.2019.09.013_bib66","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/pai.12567","article-title":"Anti-IgE assisted desensitization to egg and cow\u2019s milk in patients refractory to conventional oral immunotherapy","volume":"27","author":"Martorell-Calatayud","year":"2016","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.iac.2019.09.013_bib67","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jaci.2016.09.053","article-title":"Oral immunotherapy-induced gastrointestinal symptoms and peripheral blood eosinophil responses","volume":"139","author":"Goldberg","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.013_bib68","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.anai.2014.08.004","article-title":"Relation between eosinophilic esophagitis and oral immunotherapy for food allergy: a systematic review with meta-analysis","volume":"113","author":"Lucendo","year":"2014","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.iac.2019.09.013_bib69","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.jaci.2015.12.1316","article-title":"Long-term treatment with egg oral immunotherapy enhances sustained unresponsiveness that persists after cessation of therapy","volume":"137","author":"Jones","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.013_bib70","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s12016-018-8700-5","article-title":"Psychosocial mediators of change and patient selection factors in oral immunotherapy trials","volume":"55","author":"Dunn Galvin","year":"2018","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.iac.2019.09.013_bib71","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1111\/all.12924","article-title":"Can we identify patients at risk of life-threatening allergic reactions to food?","volume":"71","author":"Turner","year":"2016","journal-title":"Allergy"}],"container-title":["Immunology and Allergy Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088985611930075X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088985611930075X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:43:09Z","timestamp":1760179389000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088985611930075X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":71,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S088985611930075X"],"URL":"https:\/\/doi.org\/10.1016\/j.iac.2019.09.013","relation":{},"ISSN":["0889-8561"],"issn-type":[{"value":"0889-8561","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety of Food Oral Immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Immunology and Allergy Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iac.2019.09.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}